VivaVision Biotech reveals promising phase 2 trial results for VVN461, a new treatment for Non-Infectious Anterior Uveitis, ...

There are four main types of uveitis, depending on where the inflammation happens. The most common kind is called anterior uveitis, which affects the front part of your eye, including the iris and ...

Among the cases of uveitis that have been associated with the use of a sulfonamide drug, the drug involved in the majority of the cases was sulfamethoxazole (as part of the combination drug ...

The therapy also showed clinically significant reductions in anterior chamber flare (ACF ... as a treatment for non-infectious anterior uveitis, another ocular inflammatory condition.

Janus kinase (JAK) inhibitors led to improvement of uveitis in approximately half of pediatric patients previously treated with disease-modifying antirheumatic drugs (DMARDs) in a case series.

Uveitis: 1–2 drops in the eye(s ... Estimate depth of angle of anterior chamber to avoid inducing angle closure glaucoma. Infants. Pregnancy (Cat.C). Nursing mothers.

subjects treated with prednisolone acetate (p <0.001). Note: ACC (anterior chamber cells) were evaluated using SUN grading scale. Both VVN461 dose groups demonstrated statistically significant and ...

VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met primary endpoints, demonstrating non-inferior efficacy compared to the standard therapy, prednisolone acetate (PA ...